Concepedia

Trevor Beattie

TB

5

Publications

279

Citations

5

H-Index

2014

Active since

Affiliations

Aurum Institute(Current)

University of the Witwatersrand

London School of Hygiene & Tropical Medicine

University of Cape Town

Perinatal HIV Research Unit

Trevor Beattie is an author at Aurum Institute specializing in hiv, tuberculosis, and drug resistance.

Top concepts

Publications per year

2014–2025

5

Publications

5

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

Robert S. Wallis, Sibuse Ginindza, Trevor Beattie et al. · The Lancet Respiratory Medicine · 2021 · 123 citations · Full text

Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

Kelly E. Dooley, Radojkam Savic, Akshay Gupte et al. · The Lancet HIV · 2020 · 65 citations

, , +10

Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial

Klaus Reither, L. Katsoulis, Trevor Beattie et al. · PLoS ONE · 2014 · 58 citations · Full text

Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial

Robert S. Wallis, Sibuse Ginindza, Trevor Beattie et al. · PLoS ONE · 2022 · 17 citations · Full text

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

Norbert Heinrich, Veronique de Jager, Julia Dreisbach et al. · The Lancet Microbe · 2025 · 16 citations · Full text

Rows per page

1–5 of 5